ARTICLE 1 DEFINITIONSLetter Agreement • May 4th, 2011 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • New York
This Pricing Supplement is subject to the Confirmation dated as of March 1, 2011 (the “Confirmation”) between J.P. Morgan Securities LLC, as agent for JPMorgan Chase Bank, National Association, London Branch (the “Seller”), and Myriad Genetics, Inc., a Delaware corporation (the “Purchaser”). Capitalized terms used herein have the meanings set forth in the Confirmation.
